EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention

Shuai-Wen Huang iD, Hong Long, Jia-Quan Huang

Pathogens · 2024

DOI: 10.3390/pathogens14010008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, 2024. Verfasst von Shuai-Wen Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 43…. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis B, Chronic, Hepatitis B virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to the lack of agents that directly target covalently closed circular DNA and integrated HBV DNA in hepatocytes, achieving a complete cure for chronic hepatitis B (CHB) remains challenging. The latest guidelines recommend (hepatitis B surface antigen) HBsAg loss as the ideal treatment target for improving liver function, histopathology, and long-term prognosis. However, even after HBsAg loss, hepatitis B virus can persist, with a risk of recurrence, reactivation, cirrhosis, and hepatocellular carcinoma. Therefore, follow-up and surveillance are still necessary. With increasing treatment options available for achieving HBsAg loss in patients with CHB, developing effective surveillance strategies has become crucial. Recent studies on outcomes following HBsAg loss provide new insights for refining current surveillance strategies, though further improvement is needed through long-term observation and follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B Surface AntigensHepatitis B, ChronicHepatitis B virusHumansAntiviral AgentsCarcinoma, HepatocellularLiver Neoplasms

Stichwörter der Autor:innen

HBV reactivationHBV reinfectionHBsAg lossHBsAg recurrencecirrhosishepatocellular carcinomasurveillance

Substanzen

Hepatitis B Surface AntigensAntiviral Agents

Autor:innen und Institutionen

  • Department of General Practice, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China.
  • Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China.
  • Department and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China.
  • Department of Nutrition, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China.

ORCID-Profile: Shuai-Wen Huang

Förderung

  • National Science and Technology Major Project

Zitieren

APA

Huang, S. W., Long, H., & Huang, J. Q. (2024). Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention. Pathogens. https://doi.org/10.3390/pathogens14010008

Vancouver

Huang SW, Long H, Huang JQ. Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention. Pathogens. 2024. doi:10.3390/pathogens14010008

BibTeX
@article{Huang2024,
  author = {Huang, Shuai-Wen and Long, Hong and Huang, Jia-Quan},
  title = {Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens14010008}
}
Kostenlos starten →